# Individually Adapted Therapy of Alcoholism

> **NCT00317031** · PHASE4 · COMPLETED · sponsor: **Central Institute of Mental Health, Mannheim** · enrollment: 435 (actual)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** Acamprosate or Naltrexone

## Key facts

- **NCT ID:** NCT00317031
- **Lead sponsor:** Central Institute of Mental Health, Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 435 (ACTUAL)
- **Last updated:** 2008-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317031, "Individually Adapted Therapy of Alcoholism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00317031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*